Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2025-12-31 @ 3:23 PM
Study NCT ID:
NCT05007951
Status:
COMPLETED
Last Update Posted:
2024-04-08
First Post:
2021-08-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19)
Sponsor:
SK Bioscience Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-02
Completion Date Type:
ACTUAL
First Submit Date:
2021-08-09
First Submit QC Date:
None
Study First Post Date:
2021-08-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-05
Last Update Post Date:
2024-04-08
Last Update Post Date Type:
ACTUAL